BioN­Tech breaks ground on first mR­NA vac­cine man­u­fac­tur­ing fa­cil­i­ty in Africa

3 years ago
Coronavirus
Manufacturing

No­var­tis pledges $250M in R&D fund­ing for ne­glect­ed trop­i­cal dis­eases, malar­ia

3 years ago
R&D

No­var­tis broad­ens BRAF/MEK can­cer com­bo use, win­ning tu­mor-ag­nos­tic ap­proval in pa­tients 6 and up

3 years ago
FDA+

Long­wood sets an­oth­er 'don't eat me' biotech in­to gear with help of for­mer Tril­li­um CEO Jan Skvar­ka

3 years ago
Financing
Startups

As­traZeneca con­tin­ues to build out its pres­ence in Chi­na with new COPD drug man­u­fac­tur­ing site

3 years ago
China
Manufacturing

Enan­ta sues Pfiz­er, de­mand­ing com­pen­sa­tion for Paxlovid-re­lat­ed patent in­fringe­ment

3 years ago
Pharma
Law

Pfiz­er do­nates first $5M in Russ­ian prof­its since the war start­ed to help Ukraini­ans

3 years ago
Pharma

Sen­ate looks to take up House-passed mea­sure to cap in­sulin prices — a move Eli Lil­ly sup­ports

3 years ago
Pharma

FDA+ roundup: Spring reg­u­la­to­ry agen­da looks to fin­ish off Cures im­ple­men­ta­tion; GAO digs in­to med­ical ...

3 years ago
FDA+

Mod­er­na to se­cure a UK pres­ence with $1B+ in new man­u­fac­tur­ing and R&D fa­cil­i­ties

3 years ago
Pharma
Coronavirus

Gal­der­ma drug pass­es PhI­II in rare skin dis­ease, set­ting the stage for ap­proval re­quest

3 years ago
R&D

Doud­na re­search team finds CRISPR-Csm de­liv­ery po­ten­tial­ly out­per­forms RNAi, Cas13

3 years ago
Discovery

In lieu of hard M&A news, one group of an­a­lysts crunch­es the num­bers around a $40B Seagen buy

3 years ago
Deals
Bioregnum

Mer­ck out­flanks Pfiz­er's 20-va­lent shot with pneu­mo­coc­cal vac­cine ap­proval for kids

3 years ago
R&D
FDA+

Take­da to fur­ther ce­ment pres­ence in Cam­bridge, MA bio­phar­ma hub with 600,000-square-foot R&D cen­ter

3 years ago
R&D
Pharma

Klick Health treks out­side US and Cana­da to open first-ever glob­al of­fices

3 years ago
Pharma
Marketing

Mer­ck, Sanofi join No­var­tis’ 10-year quest to im­prove clin­i­cal tri­al di­ver­si­ty as his­tor­i­cal­ly Black col­leges pitch ...

3 years ago
Pharma

In pur­suit of ac­ces­si­ble sick­le cell cure, No­var­tis inks $1.5B deal to tap Pre­ci­sion's AR­CUS gene edit­ing tech

3 years ago
Deals
Cell/Gene Tx

Athi­ra’s al­ter­na­tive Alzheimer’s ap­proach runs in­to a PhII brick wall

3 years ago
R&D

Al­ladapt gets $100M+ to see its all-in-one oral im­munother­a­py al­ler­gy drug through clin­i­cal tri­als

3 years ago
Financing

Biden nom­i­nates first woman to be top, Sen­ate-con­firmed sci­ence ad­vi­sor, re­plac­ing Er­ic Lan­der

3 years ago
People
FDA+

Ab­b­Vie walks away from Mor­phic deal in af­ter­math of safe­ty sig­nal in pre­clin­i­cal test­ing

3 years ago
Deals

Mer­ck scoops up new chief mar­ket­ing of­fi­cer from Bio­gen's neu­rol­o­gy busi­ness

3 years ago
Pharma
Marketing

PIC/S to re­sume on­site as­sess­ments for coun­tries ap­ply­ing for mem­ber­ship

3 years ago
Pharma
Manufacturing
First page Previous page 509510511512513514515 Next page Last page
A service from the Financial Times